SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-02-013835
Filing Date
2002-04-05
Accepted
2002-04-05 00:00:00
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a2075936zsc13g.htm SC 13G 83511
3 EXHIBIT 1 a2075936zex-1.htm EX-1 8988
  Complete submission text file 0000912057-02-013835.txt   94799
Mailing Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405 2034888201
NEUROGEN CORP (Subject) CIK: 0000849043 (see all company filings)

IRS No.: 222845714 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-41776 | Film No.: 02602900
SIC: 2834 Pharmaceutical Preparations

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice